drug
Pulmicort
Marketedupdated 3mo agoby Par Pharmaceutical Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval8 co-mentions · 4 sources
- drugbudesonide ER6 co-mentions · 6 sources
- drugBUDESONIDE6 co-mentions · 6 sources
- drugPulmicort Turbohaler6 co-mentions · 6 sources
- drugbudesonide DR6 co-mentions · 6 sources
- tagSmall Molecule4 co-mentions · 4 sources
- tagRecall2 co-mentions · 2 sources
- drug(albuterol sulfate + budesonide)1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying Pulmicort
- phase3A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
- phase3A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
- phase3Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)
- phase4Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
- phase2Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
- phase1A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
- —Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
- phase4A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that